These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Age and 5HT 2-receptor blockade with ketanserin in essential hypertension. Bühler FR; Amstein R Rev Port Cardiol; 1989 Sep; 8(9):621-4. PubMed ID: 2698721 [TBL] [Abstract][Full Text] [Related]
3. Clinical aspects during therapy with the serotonin antagonist ketanserin. Distler A Clin Physiol Biochem; 1990; 8 Suppl 3():64-80. PubMed ID: 1983424 [TBL] [Abstract][Full Text] [Related]
4. [Blockade of 5-HT2 receptors as a mechanism of antihypertensive action of ketanserin]. Prostran M Srp Arh Celok Lek; 1994; 122(3-4):99-102. PubMed ID: 17972821 [TBL] [Abstract][Full Text] [Related]
5. [Effects of chronic antihypertensive treatment with ketanserin versus metoprolol on blood pressure and compliance of great arteries in man: a double-blind crossover study]. Crispino M Ann Ital Med Int; 1990; 5(4 Pt 2):469-76. PubMed ID: 2102134 [TBL] [Abstract][Full Text] [Related]
6. [Effects of ketanserin on arterial pressure at rest and during physical exercise in essential arterial hypertension]. Gambini G; Gradoli C; Proietti MG; Pinchi G; Fioroni E; Valori C Clin Ter; 1989 Jul; 130(2):101-7. PubMed ID: 2529082 [TBL] [Abstract][Full Text] [Related]
7. The effect of ketanserin on blood pressure and platelets during cardiopulmonary bypass. Lichtenthal PR; Wade LD; Rossi EC Anesth Analg; 1987 Nov; 66(11):1151-4. PubMed ID: 3662060 [TBL] [Abstract][Full Text] [Related]
9. Comparison of ketanserin and metoprolol in the treatment of essential hypertension. Sheps SG; Schirger A; Zachariah PK; Fisher LD; Spiekerman RE; Araas FJ; Collins JB; Agerter DC Arch Intern Med; 1987 Feb; 147(2):291-6. PubMed ID: 3545116 [TBL] [Abstract][Full Text] [Related]
10. [A new antihypertensive: ketanserin]. Salvini P Riv Eur Sci Med Farmacol; 1989 Feb; 11(1):77-84. PubMed ID: 2678304 [TBL] [Abstract][Full Text] [Related]
11. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients. de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159 [TBL] [Abstract][Full Text] [Related]
12. Antihypertensive efficacy of ketanserin alone or in combination with a beta-blocker or a diuretic: the Swiss Ketanserin Study. Beretta-Piccoli C; Amstein R; Bertel O; Brunner HR; Bühler FR; Follath F; Solèr M; Vallotton M J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S119-23. PubMed ID: 2446058 [TBL] [Abstract][Full Text] [Related]
13. Age and the platelet serotonin vasoconstrictor axis in essential hypertension. Amstein R; Fetkovska N; Lüscher TF; Kiowski W; Bühler FR J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S35-40. PubMed ID: 2459512 [TBL] [Abstract][Full Text] [Related]
14. Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease. Podoleanu D; Cotoi S Rom J Intern Med; 1996; 34(1-2):49-54. PubMed ID: 8908630 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of acute and chronic effects of ketanserin in the treatment of hypertension and hypothesis on a new mechanism of action]. Sechi LA Ann Ital Med Int; 1990; 5(4 Pt 2):433-50. PubMed ID: 2102130 [TBL] [Abstract][Full Text] [Related]
16. Experience with ketanserin and ritanserin in hypertensive patients. Hedner T; Persson B J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S44-8. PubMed ID: 2459514 [TBL] [Abstract][Full Text] [Related]
17. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials]. Oparil S; Bakir SE Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856 [TBL] [Abstract][Full Text] [Related]
18. Ketanserin (S2-receptor blocking agents), hypertension and chronic alcoholism. De Lorenzo A; Ceccanti M; Romeo M; Pisculli M; Di Giovanni MG; Lais A; Assogna G; Valgiusti FC Int J Clin Pharmacol Res; 1986; 6(1):77-9. PubMed ID: 2937747 [TBL] [Abstract][Full Text] [Related]
19. The antihypertensive efficacy of ketanserin in the elderly evaluated by ambulatory blood pressure measurement. McCormack PM; Cox JP; Marron J; Mee F; Atkins N; O'Brien E; O'Malley K J Hum Hypertens; 1990 Oct; 4(5):565-70. PubMed ID: 2283647 [TBL] [Abstract][Full Text] [Related]
20. Moderate essential hypertension control: a double-blind crossover study between a serotonin antagonist and a post-synaptic alpha-blocker. Rosenthal J; Koehle W; Gruebel B; Fisher R J Hypertens Suppl; 1986 Apr; 4(1):S85-7. PubMed ID: 2871145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]